ABSTRACT
Both common and rare genetic variants (minor allele frequency > 1% and < 0.1% respectively) have been implicated in the aetiology of schizophrenia. In this study, we integrate single-cell gene expression data with publicly available Genome-Wide Association Study (GWAS) and exome sequenced data in order to investigate in parallel, the enrichment of common and (ultra-)rare variants related to schizophrenia in several functionally relevant gene-sets. Four types of gene-sets were constructed 1) protein-truncating variant (PTV)-intolerant (PI) genes 2) genes expressed in brain cell types and neurons ascertained from mouse and human brain tissue 3) genes defined by synaptic function and location and 4) intersection genes, i.e., PI genes that are expressed in the human and mouse brain cell gene-sets. We show that common as well as ultra-rare schizophrenia-associated variants are overrepresented in PI genes, in excitatory neurons from the prefrontal cortex and hippocampus, medium spiny neurons, and genes enriched for synaptic processes. We also observed stronger enrichment in the intersection genes. Our findings suggest that across the allele frequency spectrum, genes and genetic variants likely to be under stringent selection, and those expressed in particular brain cell types, are involved in the same biological pathways influencing the risk for schizophrenia.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This project has received funding from the European Union Horizon 2020 research and innovation programme, Marie Sklodowska Curie Actions MSCA-ITN-2016 Innovative Training Networks under grant agreement No [721567]. W.A.A. is additionally supported by the National Institute Of Mental Health of the National Institutes of Health under Award Number R01MH120219. A.R.H. is supported by the Childrens Hospital Foundation and University of Queensland strategic funding. M.B. is funded by an ERC Consolidator Grant (WELL-BEING 771057). M.G.N is supported by the National Institute Of Mental Health of the National Institutes of Health under Award Number R01MH120219, ZonMW grants 849200011 and 531003014 from The Netherlands Organisation for Health Research and Development, a VENI grant awarded by The Dutch Research Council (NWO) (VI.Veni.191G.030) and is a Jacobs Foundation Fellow.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This research was approved by The Scientific and Ethical Review Board (VCWE) of the Faculty of Behavior & Movement Sciences, VU University Amsterdam. We used de-identified GWAS summary statistics for the common variant analyses reported in the current study. For those no IRB approval is required.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵* Jointly supervised the work
Data Availability
GWAS summary statistics used in the analyses are publicly available for download, with sources provided in the manuscript. Schizophrenia exome sequenced data are available from dbGAP upon successful data application. The dbGAP study accession number is provided in the data availability section of the manuscript. Gene sets sources are described in the data availability section of the manuscript, and those included in the analyses are included in as supplementary materials.
https://gtexportal.org/home/datasets
https://www.nature.com/articles/s41588-018-0129-5#Sec33
http://www.informatics.jax.org/downloads/reports/HOM_MouseHumanSequence.rpt
